Dr. Vogl - ASH 2008 - Combined Autophagy and Proteasome Inhibition for Multiple Myeloma: Preliminary Results of a Phase 1/2 Trial of Hydroxychloroquine and Standard Dose Bortezomib for Relapsed or Refractory Myeloma
Dan T. Vogl, MD Abramson Cancer Center, University of Pennsylvania School of Medicine Myeloma Program Philadelphia, Pennsylvania USA
To view the video full screen, click on the small
button next to the volume control in the
lower right hand corner.